Molecular Identity
Terazosin
[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(oxolan-2-yl)methanone
PubChem CID: 5401
Terazosin is a member of furans, a member of piperazines, a member of quinazolines and a primary amino compound. It has a role as an antineoplastic agent, an antihypertensive agent and an alpha-adrenergic antagonist.
2D Structure
Properties
C19H25N5O4
Molecular Formula
387.40
Molecular Weight
g/mol
387.1907
Exact Mass
Da
1.4
XLogP
Drug-like (Lipinski: < 5)
103
TPSA
Good oral absorption (< 140 A²)
1
H-Bond Donors
8
H-Bond Acceptors
544
Complexity
SMILES
Canonical SMILES
SMILES: COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OCIsomeric SMILES
SMILES: COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OCSynonyms(20)
terazosin63590-64-7TerazosineFosfomicTerazosinaBlavinFlumarcTerazosinumTerazosabb1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)piperazineHytrinexVicard8L5014XET7CHEBI:9445DTXSID3023639
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Terazosin
Loading drug network...